Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOPEmultiPFA: Ticagrelor vs Clopidogrel in HPR ACS Patients
NCT02699008Completed
- Sponsor
- Wuhan Asia Heart Hospital
- Start
- Jan 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ticagrelor in acute coronary syndrome (ACS) (3 arms), sponsored by Wuhan Asia Heart Hospital. Primary endpoint: Major Adverse Cardiovascular Events at 1 year. Started Jan 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02699008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02699008.